Newsmeme!
Discover News you didn't know existed
(Adds details) Nov 20 (Reuters) - Jazz Pharmaceuticals Inc said its experimental treatment for fibromyalgia, a chronic pain syndrome, met the main goal of reducing pain and fatigue in the first of two late-stage trials. In the study that enrolled 548 patients, the company said sodium oxybate, or JZP-6, reduced at least 30 percent pain or more in both the 4.5 gram and 6 gram dosages compared to a ...
No tags found at this time. Be the first to tag this news item, learn more.
No related news stories found.
None found at this time.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |